vanflyta
daiichi sankyo europe gmbh - quizartinib dihydrochloride - białaczka, szpikowe - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.
ascodan 400 mg + 8 mg tabletki
zakłady farmaceutyczne polpharma s.a. - acidum acetylsalicylicum + codeini phosphas - tabletki - 400 mg + 8 mg
leponex 100 mg tabletki
mylan healthcare sp. z o.o. - clozapinum - tabletki - 100 mg
pridinol zentiva 5 mg tabletki
zentiva, k.s. - pridinoli hydrochloridum - tabletki - 5 mg
leponex 25 mg tabletki
mylan healthcare sp. z o.o. - clozapinum - tabletki - 25 mg
symcloza 25 mg tabletki
symphar sp. z o.o. - clozapinum - tabletki - 25 mg
symcloza 50 mg tabletki
symphar sp. z o.o. - clozapinum - tabletki - 50 mg
symcloza 100 mg tabletki
symphar sp. z o.o. - clozapinum - tabletki - 100 mg
symcloza 200 mg tabletki
symphar sp. z o.o. - clozapinum - tabletki - 200 mg
paxifar 100 mg tabletki
biofarm sp. z o.o. - clozapinum - tabletki - 100 mg